References
- Rittmaster R. Hirsutism. Lancet 1997;349:191–5
- Escobar-Morreale HF, Serraro-Gottaredona J, Garcia-Robles R, et al. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopatic hirsutism exist? Metabolism 1997;46:902–7
- Lobo RA, Goebelsmann U, Horton R. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 1983;57:393–9
- Lobo RA. Hirsutism in polycystic ovary syn-drome: current concepts. Clin Obstet Gynecol 1991; 34:817–26
- Gaspard UJ, Manette C. Low dose combined oral contraceptive therapy in polycystic ovary syndrome: a review. Ann NY Acad Sci 1993;687:345–9
- Greep N, Hoopes M, Horton R. Androstenediol glucuronide plazma clearance and production rates in normal and hirsute women. J Clin Endocrinol Metab 1986;62:22
- Rittmaster RS. Clinical relevance of testosterone and dihydrotestosterone metabolism in women. AmJ Med 1995;98(Suppl):175–215
- Azziz R, Waggoner WT, Ochoa T, et al. Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. Fertil Steril 1998;70:274–8
- Melegos DN, Yu H, Ashok M, et al. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997;82: 777–80
- Escobar-Morreale HF, Serrano-Gottaredona J, Avila S, et al. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab 1998;83: 2580–4
- Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21:1440–7
- Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Dunaif A, Givens JR, Haseltine F, et al, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific, 1992:377–84
- WHO Expert Committee. Physical Status: the Use and Interpretation of Anthropometri. WHO Technical Report Series No.854. Geneva: World Health Organization, 1995
- Ferguson R, Yu H, Kalyvas M, et al. Ultra-sensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675–84
- Chrisp P, Goa KL. Nafarelin. A review of its pharmacodynamic and pharrnocokinetic properties and clinical potential in sex hormone-related con-ditions. Drug 1990;39:523–51
- Serafini P, Lobo RA. Increased 5a-reductase activity in idiopatic hirsutism. Fertil Steril 1985;43:74–8
- Yiicelten D, Erenus M, Giirbilz 0, et al. Recurrence rate of hirsutism after 3 different antiandrogen therapies. J Am Acad Dermatol 1999;41: 64–8
- Fruzetti F, Chiara B, Parrini D, et al. Treatment of hirsutism: comparisons between different anti-androgens with central and peripheral effects. Fertil Steril 1999;71:445–51
- Diamandis EP, Yu H. New biological functions of prostate-specific antigen? J Gun Endocrinol Metab 1995;80:1515–7
- Diamandis EP, Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997; 24:275–82
- Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995; 41:204–10
- Malatesta M, Mannello F, Luchetti F, et al. Prostate-specific antigen synthesis and secretion by human placenta: a physiological kallikrein source during pregnancy. J Clin Endocrinol Metab 2000; 85:317–21
- Zarghami N, Grass L, Sauter ER, et al. Prostate-specific antigen in serum during the menstrual cycle. Clin Chem 1997;43:1862–7
- Escobar-Morreale HF, Sancho JM, Serraro-Gottaredona J, et al. Lack of an ovarian function influence on the increased adrenal secretion present in women with functional ovarian hyperandrogenism. Fertil Steril 1997;67:654–62
- Negri C, Tosi F, Dorizzi R, etal. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.J Clin Endocrinol Metab 2000;85:81–4
- Escobar-Morreale HF, Avila S, Sancho J. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills. J Clin Endocrinol Metab 2000;85: 2488–92
- Pazos F, Escobar-Morreale HF, Balsa J, et al. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide and cyproterone acetate used in combination with an oral contraceptive, in the treatment of hirsutism. Fertil Steril 1999;71: 122–8.